Skip to main content
main-content

01.03.2012 | Short Communication | Ausgabe 3/2012

European Journal of Nuclear Medicine and Molecular Imaging 3/2012

Microvascular dysfunction in nonfailing arrhythmogenic right ventricular cardiomyopathy

Zeitschrift:
European Journal of Nuclear Medicine and Molecular Imaging > Ausgabe 3/2012
Autoren:
Matthias Paul, Kambiz Rahbar, Joachim Gerss, Peter Kies, Otmar Schober, Klaus Schäfers, Günter Breithardt, Eric Schulze-Bahr, Thomas Wichter, Michael Schäfers
Wichtige Hinweise
Matthias Paul and Kambiz Rahbar contributed equally to this work.

Abstract

Purpose

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a nonischaemic cardiomyopathy and leading cause of sudden death in the young. It has been shown that microvascular dysfunction reflected by an impaired myocardial blood flow (MBF) response to stress is present in patients with other forms of nonischaemic cardiomyopathy, e.g. dilated cardiomyopathy, and that the reduced MBF may be related to a poor prognosis. Therefore, we quantified MBF, coronary flow reserve and coronary vascular resistance in patients with nonfailing ARVC using H 2 15 O and PET.

Methods

In ten male patients with ARVC (mean age 49 ± 14 years), MBF was quantified at rest and during adenosine-induced hyperaemia using H 2 15 O PET. Results were compared with those obtained in 20 age-matched healthy male control subjects (mean age 46 ± 14 years).

Results

Resting MBF was not significantly different between patients with ARVC and controls (MBFrest 1.19 ± 0.29 vs. 1.12 ± 0.20 ml/min/ml). However, hyperaemic MBF was significantly lower in patients with ARVC than in controls (2.60 ± 0.96 vs. 3.68 ± 0.84 ml/min/ml; p = 0.005). Consequently, patients with ARVC had a significantly lower coronary flow reserve than control subjects (2.41 ± 1.34 vs. 3.39 ± 0.93; p = 0.030). In addition, hyperaemic coronary vascular resistance was increased in patients with ARVC (36.79 ± 12.91 vs. 26.31 ± 6.49 mmHg × ml-1 × min × ml; p = 0.007), but was found to be unchanged at rest.

Conclusion

In this small well-characterized cohort of patients with nonfailing ARVC, we found a significantly reduced hyperaemic MBF and increased coronary vascular resistance. Further studies are necessary to corroborate this potential new functional aspect of the pathophysiological mechanisms underlying ARVC.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 3/2012

European Journal of Nuclear Medicine and Molecular Imaging 3/2012 Zur Ausgabe
  1. Sie können e.Med Radiologie 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.